IP Library Granted Patent US 7,358,352
Granted Patent B2
US 7,358,352 · App. 11/598,469 · Granted Apr 15, 2008

Nucleic acids encoding human TNF-α convertase

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,358,352
App. No.
11/598,469
Granted
Apr 15, 2008
Kind
B2
Abstract

The present invention provides isolated human and bovine TNF-α convertases, nucleic acids and; recombinant vectors encoding the same, host cells comprising the nucleic acids and vectors, and methods for making the convertases using the host cells. This invention further provides antibodies and antigen binding fragments thereof which specifically bind to the convertases and are useful for treating medical conditions caused or mediated by TNF-α. Also provided are screening methods for identifying specific inhibitors of mammalian TNF-α convertases, and for identifying nucleic acids encoding such convertases.

Claims (6)

1. An isolated or recombinant nucleic acid encoding the protein of SEQ ID NO: 23.

2. The nucleic acid of claim 1 which comprises the nucleotide sequence of SEQ ID NO: 21.

3. A recombinant vector comprising a nucleic acid of claim 1 .

4. An isolated host cell comprising a recombinant vector of claim 3 .

5. A method for making a protein comprising culturing a host cell of claim 4 under conditions in which the nucleic acid is expressed.

6. The method of claim 5 in which the protein is isolated from the culture.

Assignments (1)
CHANGE OF NAME Recorded Aug 30, 2012
From: SCHERING CORPORATION
To: MERCK SHARP & DOHME CORP.
Reel/Frame 028884/0151 →